Search results
Andrew Arno is a managing director for William Blair based in the firm’s San Francisco office. He joined William Blair's investment banking team in 2004. Prior to William Blair, he worked for WR Hambrecht and The Shattan Group.
School of Medicine / Departments / Radiation Medicine / Our Team / Radiation Oncology Division. Team Overview. Radiation Oncology Division. Medical Physics Division. Applied Sciences Division. . Radiation Oncology Division.
Clinical Focus Prostate Cancer, Dupuytren’s Contracture, Cardiac SBRT (Arrhythmias), and Gynecologic Cancers. Dr. Arno J. Mundt is a Professor and Founding Chair of the Department of Radiation Medicine & Applied Sciences and a member of the Executive Governing Committee of the Moores Cancer Center.
Jul 24, 2023 · 22nd Century Group, Inc. appointed Wall Street veteran Andrew (?Andy?) Arno to its Board of Directors as an independent director. Mr. Arno has 35+ years of experience handling a wide range of corporate and financial matters, including work as an investment banker, strategic advisor and board member to emerging growth companies. Mr.
- The Last 12 Months of Insider Transactions at OncoCyte
- Insider Ownership
- What Might The Insider Transactions at OncoCyte Tell Us?
In fact, the recent purchase by Andrew Arno was the biggest purchase of OncoCyte shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at above the current price of US$0.90. It's very possible they regret the purchase, but it's more likely they are bullish about ...
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Our data indicates that OncoCyte insiders own about US$9.0m worth of shares (which is 8...
The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. While the overall levels of insider ownership are below what we'd like to see, the history of transactions imply that OncoCyte insiders are reasonably w...
Estate Planning. Charitable Planning. Employee Benefits. Financial Advisor offering securities and advisory services through Cetera Advisors LLC, member FINRA/SIPC. a broker/dealer and Registered...
- PROFESSIONAL PLANNING ASSOCIATES, INC.
View Andrew Arno’s profile on LinkedIn, a professional community of 1 billion members. Senior technology investment banking professional focused on providing advice to…
- William Blair
